Dual incontinence is when a patient is experiencing both bladder and bowel control symptoms.
Your doctor and his or her clinical team will follow a patient care pathway, which is a roadmap of the different treatment options available to you. The pathway starts with conservative treatments and then moves on to the advanced therapies.
Clinically Proven. Patient Approved.
Backed by clinical studies, Axonics Therapy is clinically proven to regain bowel and bladder control and deliver clinically meaningful improvement in quality of life.
At 2-Years,
- 87% of FI patients had ≥50% reduction in FI episodes3
- 82% of urinary incontinence patients* were satisfied with Axonics Therapy at two years2
Real stories. Real results.
Doris K. 71 years old
Doris had suffered with overactive bladder and bowel symptoms since 1987. “The thing that stands out in my mind the most is that this has gone on for so many years and I had to adjust my whole life.” Finally, with Sacral Neuromodulation therapy from Axonics, Doris got her symptoms under control and was able to say “goodbye” to wearing pads!
“I adjusted my whole life by limiting myself from drinking and eating. Now I don’t have to.”
Results and experiences may vary and are unique to each patient.
Get the symptom relief you deserve!
Ready to take the first step towards symptom relief? Schedule a consultation with your doctor to discuss your symptoms and to determine if Axonics Therapy is right for you.
Important Safety Information:
Indications: Axonics SNM Therapy for urinary control is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments. Axonics SNM Therapy for bowel control is indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.
Contraindications: Axonics SNM Therapy is contraindicated for patients who have not demonstrated an appropriate response to test stimulation or patients who are unable to operate the Axonics SNM Systems.
Warnings: Implantation and use of the Axonics Systems incur risks beyond those normally associated with surgery, some of which may necessitate surgical intervention. These risks include, but are not limited to adverse change in voiding function (bowel and/or bladder), infection, pain or irritation at the implant site, lead or device migration, electrical shock, change in sensation or magnitude of stimulation which has been described as uncomfortable (jolting or shocking) by some patients, and heating or burns at the device site.Results and experiences may vary and are unique to each patient. No promise or guarantee is made about specific results or experiences. Talk to your doctor to see if Axonics Therapy is right for you and to discuss the potential risks and benefits.For more information about safety and potential risks, go to www.axonics.com/isi.
Precautions: The safety and effectiveness of Axonics Therapy has not been established for use in women who are pregnant or in delivery; for pediatric patients (under the age of 18 years for fecal incontinence and under the age of 16 years for overactive bladder and urinary retention); for patients with neurological diseases, such as multiple sclerosis or diabetes, or for bilateral stimulation.
